AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Insights - AbbVie is focused on continuing its strategic priorities into 2026, emphasizing strong operational execution and advancing its pipeline [1] Group 1: Business Strategy - The company aims to deliver strong financial results through effective operational execution [1] - Advancing the pipeline remains a key priority for AbbVie as it looks towards future growth [1] Group 2: Historical Context - There was significant uncertainty surrounding the launch of HUMIRA's loss of exclusivity (LOE), but AbbVie has successfully navigated this challenge [2] - The company is preparing to announce its 2025 guidance, indicating ongoing confidence in its financial outlook [2]